Skip to main content
Latest News
December 17, 2021
Bristol Myers Squibb to Report Results for Fourth Quarter 2021 on February 4, 2022
December 15, 2021
U.S. Food and Drug Administration Approves Orencia® (abatacept) in Combination with a Calcineurin Inhibitor and Methotrexate for the Prevention of Acute Graft Versus Host Disease (aGvHD)...
December 14, 2021
Immatics and Bristol Myers Squibb Enter Into Global Exclusive License for Immatics’ TCR Bispecific Program IMA401
Latest Events
Event year list
2026
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
November 17, 2021
08:45 AM ET
Wolfe Research Virtual Healthcare Conference 2021
Webcast
(opens in new window)
November 16, 2021
09:30 AM ET
Bristol Myers Squibb Investor Event
Webcast
(opens in new window)
View this presentation
(opens in new window)
(
PDF
7.77 MB
)
Appendix - EPI Slides
(opens in new window)
(
PDF
326 KB
)
October 27, 2021
10:00 AM ET
Bristol Myers Squibb Q3 2021 Results Conference Call
Webcast
(opens in new window)
Press Release
Quarterly Package of Financial Information (XLS)
(opens in new window)
(
Excel
2.33 MB
)
Press Release (PDF)
(opens in new window)
(
PDF
429 KB
)
View this presentation
(opens in new window)
(
PDF
2.84 MB
)